Cargando…
Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort
Retinal vein occlusion (RVO) is an obstruction of the retinal venous system, and macular edema (ME) is a complication of RVO that can lead to blindness. The Canadian incidence of visual impairment (VI) due to ME secondary to RVO is unknown. This observational, retrospective study used records from t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477564/ https://www.ncbi.nlm.nih.gov/pubmed/23097691 http://dx.doi.org/10.1155/2012/723169 |
_version_ | 1782247233049067520 |
---|---|
author | Petrella, Robert J. Blouin, Julie Davies, Brian Barbeau, Martin |
author_facet | Petrella, Robert J. Blouin, Julie Davies, Brian Barbeau, Martin |
author_sort | Petrella, Robert J. |
collection | PubMed |
description | Retinal vein occlusion (RVO) is an obstruction of the retinal venous system, and macular edema (ME) is a complication of RVO that can lead to blindness. The Canadian incidence of visual impairment (VI) due to ME secondary to RVO is unknown. This observational, retrospective study used records from the Southwestern Ontario database to observe the annual incidence, demographics, and comorbidity characteristics of patients with VI due to ME secondary to RVO. From 47,166 patients, 73 with RVO (>40 years old) were identified: 53 with branch retinal vein occlusion (BRVO), 20 with central retinal vein occlusion (CRVO). The annual incidence of VI (visual acuity <20/40 in Snellen equivalent) due to ME secondary to BRVO was (mean (95%CI)) 0.056% (0.011–0.072), and to CRVO was 0.021% (0.008–0.081). Furthermore, a greater proportion of RVO patients had hypertension (68% versus 14%) or dyslipidemia (16% versus 10%), when compared to a healthy control cohort of 76,077 subjects (P < 0.05). This study presents a description of the characteristics of patients with VI due to ME secondary to RVO in a real-world Canadian setting. The results demonstrate that BRVO was more frequent than CRVO, and that RVO in this patient population was associated with several vascular comorbidities. |
format | Online Article Text |
id | pubmed-3477564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34775642012-10-24 Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort Petrella, Robert J. Blouin, Julie Davies, Brian Barbeau, Martin J Ophthalmol Clinical Study Retinal vein occlusion (RVO) is an obstruction of the retinal venous system, and macular edema (ME) is a complication of RVO that can lead to blindness. The Canadian incidence of visual impairment (VI) due to ME secondary to RVO is unknown. This observational, retrospective study used records from the Southwestern Ontario database to observe the annual incidence, demographics, and comorbidity characteristics of patients with VI due to ME secondary to RVO. From 47,166 patients, 73 with RVO (>40 years old) were identified: 53 with branch retinal vein occlusion (BRVO), 20 with central retinal vein occlusion (CRVO). The annual incidence of VI (visual acuity <20/40 in Snellen equivalent) due to ME secondary to BRVO was (mean (95%CI)) 0.056% (0.011–0.072), and to CRVO was 0.021% (0.008–0.081). Furthermore, a greater proportion of RVO patients had hypertension (68% versus 14%) or dyslipidemia (16% versus 10%), when compared to a healthy control cohort of 76,077 subjects (P < 0.05). This study presents a description of the characteristics of patients with VI due to ME secondary to RVO in a real-world Canadian setting. The results demonstrate that BRVO was more frequent than CRVO, and that RVO in this patient population was associated with several vascular comorbidities. Hindawi Publishing Corporation 2012 2012-10-14 /pmc/articles/PMC3477564/ /pubmed/23097691 http://dx.doi.org/10.1155/2012/723169 Text en Copyright © 2012 Robert J. Petrella et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Petrella, Robert J. Blouin, Julie Davies, Brian Barbeau, Martin Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort |
title | Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort |
title_full | Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort |
title_fullStr | Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort |
title_full_unstemmed | Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort |
title_short | Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort |
title_sort | incidence and characteristics of patients with visual impairment due to macular edema secondary to retinal vein occlusion in a representative canadian cohort |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477564/ https://www.ncbi.nlm.nih.gov/pubmed/23097691 http://dx.doi.org/10.1155/2012/723169 |
work_keys_str_mv | AT petrellarobertj incidenceandcharacteristicsofpatientswithvisualimpairmentduetomacularedemasecondarytoretinalveinocclusioninarepresentativecanadiancohort AT blouinjulie incidenceandcharacteristicsofpatientswithvisualimpairmentduetomacularedemasecondarytoretinalveinocclusioninarepresentativecanadiancohort AT daviesbrian incidenceandcharacteristicsofpatientswithvisualimpairmentduetomacularedemasecondarytoretinalveinocclusioninarepresentativecanadiancohort AT barbeaumartin incidenceandcharacteristicsofpatientswithvisualimpairmentduetomacularedemasecondarytoretinalveinocclusioninarepresentativecanadiancohort |